Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AIL viral integration site to 14q13.3-q21.1

BMC Genomics

Volumn 4, Issue , 2003, Pages

  Gough, Sheryl M ^a   McDonald, Margaret ^a   Chen, Xiao Ning ^b   Korenberg, Julie R ^b   Neri, Antonino ^c   Kahn, Tomas ^d   Eccles, Michael R ^e   Morris, Christine M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d Deutsches Bank AG   (Germany)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG; ONCOPROTEIN; TRANSCRIPTION FACTOR PAX2;

BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 14Q; CHROMOSOME REARRANGEMENT; CONDYLOMA; CONTROLLED STUDY; DNA FLANKING REGION; DNA INTEGRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ISOLATION; GENE LOCATION; GENE MAPPING; GENE TRANSFER; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC SELECTION; GENETIC STABILITY; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PUBLICATION; REVIEW; SCIENTIFIC LITERATURE; TERMINAL SEQUENCE; TONSIL CARCINOMA; VIRUS DNA CELL DNA INTERACTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 6A;

EID: 9444265262     PISSN: 14712164     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2164-4-9     Document Type: Review

References (71)

1. Gray IC, Fallowfield J, Ford S, Nobile C, Volpi EV and Spurr NK An integrated physical and genetic map spanning chromosome band 10q24. Genomics 1997, 43:85-88
2. Nikali K, Isosomppi J, Lonnqvist T, Mao JI, Suomalainen A and Peltonen L Toward cloning of a novel ataxia gene: refined assignment and physical map of the IOSCA locus (SCA8) on 10q24. Genomics 1997, 39:185-191
3. Ford S, Gray IC and Spurr NK Rearrangement of the long arm of chromosome 10 in the prostate adenocarcinoma cell line LNCaP. Cancer Genet Cytogenet 1998, 102:6-11
4. Nobile C, Manca A, Pisano M, Angius A, Gray IC and Spurr NK A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders. Mamm Genome 1998, 9: 35-837
5. Dear TN, Sanchez-Garcia I and Rabbitts TH The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. Proc Natl Acad Sci U S A 1993, 90:4431-4435
6. Roberts CW, Shutter JR and Korsmeyer SJ Hox11 controls the genesis of the spleen. Nature 1994, 368:747-749
7. Dear TN, Colledge WH, Carlton MB, Lavenir I, Larson T, Smith AJ, Warren AJ, Evans MJ, Sofroniew MV and Rabbitts TH The Hox11 gene is essential for cell survival during spleen development. Development 1995, 121:2909-2915
8. Hatano M, Roberts CW, Minden M, Crist WM and Korsmeyer SJ Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991, 253:79-82
9. Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T and Rabbitts TH HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci U S A 1991, 88: 900-8904
10. Salvati PD, Ranford PR, Ford J and Kees UR HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. Oncogene 1995, 11:1333-1338
11. Salvati PD, Watt PM, Thomas WR and Kees UR Molecular characterization of a complex chromosomal translocation breakpoint t(10;14) including the HOX11 oncogene locus. Leukemia 1999, 13:975-979
12. Watt PM, Kumar R, Kees UR, Salvati PD, Thomas WR, Ranford PR and Ford J Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia. Genes Chromosomes Cancer 2000, 29:371-377
13. Kahl C, Gesk S, Harder L, Harbott J, French L, Deloukas P, Grote W, Schlegelberger B and Siebert R Detection of translocations involving the HOX11/TCL3-locus in 10q24 by interphase fluorescence in situ hybridization. Cancer Genet Cytogenet 2001, 129: 0-804
14. Porteous S, Torban E, Cho NP, Cunliffe H, Chua L, McNoe L, Ward T, Souza C, Gus P and Giugliani R Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. Hum Mol Genet 2000, 9:1-11
15. Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD and Ogden CW Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J Urol 2001, 165:2115-2120
16. Silberstein GB, Dressler GR and Van Horn K Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene 2002, 21: 009-1016
17. Dressler GR and Woolf AS Pax2 in development and renal disease. Int J Dev Biol 1999, 43:463-468
18. Eccles MR, He S, Legge M, Kumar R, Fox J, Zhou C, French M and Tsai RW PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol 2002, 46: 35-544
19. Chen F, Castranova V, Shi X and Demers LM New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999, 45:7-17
20. Karin M, Cao Y, Greten FR and Li ZW NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2:301-310
21. Neri A, Fracchiolla NS, Migliazza A, Trecca D and Lombardi L The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. Leuk Lymphoma 1996, 23:43-48
22. Kim KE, Gu C, Thakur S, Vieira E, Lin JC and Rabson AB Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. Oncogene 2000, 19:1334-1345
23. Chernova OB, Somerville RP and Cowell JK A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881
24. Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, Saenz A, Poza JJ, Galan J, Gesk S, Sarafidou T, Mautner VF and Binelli S Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002, 11: 119-1128
25. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, Martinelli Boneschi F, Choi C, Morozov P, Das K and Teplitskaya E Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002, 30:335-341
26. Virmani AK, Fong KM, Kodagoda D, McIntire D, Hung J, Tonk V, Minna JD and Gazdar AF Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 1998, 21:308-319
27. Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK and Mao L Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clinical Cancer Research 2000, 6:559-565
28. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H and Mitelman F Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992, 4:16-24
29. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 1995, 55:4800-4803
30. Prochownik EV, Eagle Grove L, Deubler D, Zhu XL, Stephenson RA, Rohr LR, Yin X and Brothman AR Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes Chromosomes Cancer 1998, 22:295-304
31. Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C, Tanke HJ, Schroder FH and van Dekken H Identification of genetic markers for prostatic cancer progression. Laboratory Investigation 2000, 80:931-942
32. Cabeza-Arvelaiz Y, Thompson TC, Sepulveda JL and Chinault AC LAPSER1: a novel candidate tumor suppressor gene from 10q24.3. Oncogene 2001, 20:6707-6717
33. Leube B, Drechsler M, Muhlmann K, Schafer R, Schulz WA, Santourlidis S, Anastasiadis A, Ackermann R, Visakorpi T and Muller W Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer. Prostate 2002, 50:135-144
34. Cappellen D, Gil Diez de Medina S, Chopin D, Thiery JP and Radvanyi F Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 1997, 14:3059-3066
35. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L and Terpe HJ Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998, 185:345-351
36. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch MJ, Gasser TC and Sauter G Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 1999, 59:5687-5691
37. Parmiter AH, Balaban G, Clark WH Jr and Nowell PC Possible involvement of the chromosome region 10q24-q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet 1988, 30: 13-317
38. Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T and Reifenberger G Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 2002, 100:549-556
39. Speaks SL, Sanger WG, Masih AS, Harrington DS, Hess M and Armitage JO Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer 1992, 5: 39-243
40. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ, Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M and Sakon M Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000, 95:2937-2942
41. Wilson KS, McKenna RW, Kroft SH, Dawson DB, Ansari Q and Schneider NR Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol 2002, 116:113-121
42. Kahn T, Turazza E, Ojeda R, Bercovich A, Stremlau A, Lichter P, Poustka A, Grinstein S and zur Hausen H Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 1994, 54:1305-1312
43. Trask BJ, Massa H, Kenwrick S and Gitschier J Mapping of human chromosome Xq28 by two-color fluorescence in situ hybridization of DNA sequences to interphase cell nuclei. Am J Hum Genet 1991, 48:1-15
44. Senger G, Ragoussis J, Trowsdale J and Sheer D Fine mapping of the human MHC class II region within chromosome band 6p21 and evaluation of probe ordering using interphase fluorescence in situ hybridization. Cytogenetics & Cell Genetics 1993, 64:49-53
45. IHGS Consortium Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921
46. Chernova O and Cowell JK Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells. Cancer Genet Cytogenet 1998, 105: 60-68
47. Jonkers J, Korswagen HC, Acton D, Breuer M and Berns A Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. Embo J 1997, 16:441-450
48. Saitoh T, Moriwaki J, Koike J, Takagi A, Miwa T, Shiokawa K and Katoh M Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. Biochemical & Biophysical Research Communications 2001, 281:815-820
49. Saitoh T, Mine T and Katoh M Up-regulation of WNT8B mRNA in human gastric cancer. International Journal of Oncology 2002, 20:343-348
50. Yoshiura K, Leysens NJ, Chang J, Ward D, Murray JC and Muenke M Genomic structure, sequence, and mapping of human FGF8 with no evidence for its role in craniosynostosis/limb defect syndromes. Am J Med Genet 1997, 72:354-362
51. Heckel D, Comtesse N, Brass N, Blin N, Zang KD and Meese E Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet 1998, 7:1859-1872
52. Stone DM, Murone M, Luoh S, Ye W, Armanini MP, Gurney A, Phillips H, Brush J, Goddard A and de Sauvage FJ Characterization of the human suppressor of fused, a negative regulator of the zincfinger transcription factor Gli. J Cell Sci 1999, 112:4437-4448
53. Vincent SR, Kwasnicka DA and Fretier P A novel RING finger-B box-coiled-coil protein, GERP. Biochem Biophys Res Commun 2000, 279:482-486
54. Nobile C and Pitzalis S Expression analysis of 21 transcripts physically anchored within the chromosomal region 10q24 [In Process Citation]. Genomics 1999, 62:86-89
55. Lo Nigro C, Cusano R, Scaranari M, Cinti R, Forabosco P, Morra VB, De Michele G, Santoro L, Davies S and Hurst J A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2. Eur J Hum Genet 2000, 8:777-782
56. Verhoeven K, Villanova M, Rossi A, Malandrini A, De Jonghe P, Timmerman V, Saitoh T and Katoh M Localization of the gene for the intermediate form of charcot-marie-tooth to chromosome 10q24.1-q25.1. Am J Hum Genet 2001, 69:889-894
57. Jeon S and Lambert PF Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995, 92:1654-1658
58. Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P and von Knebel Doeberitz M Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001, 92:9-17
59. Einstein MH, Cruz Y, El-Awady MK, Popescu NC, DiPaolo JA, van Ranst M, Kadish AS, Romney S, Runowicz CD and Burk RD Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman. Clin Cancer Res 2002, 8:549-554
60. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U and Doeberitz MK Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 2002, 21:419-426
61. Durst M, Croce CM, Gissmann L, Schwarz E and Huebner K Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A 1987, 84: 070-1074
62. Reuter S, Bartelmann M, Vogt M, Geisen C, Napierski I, Kahn T, Delius H, Lichter P, Weitz S and Korn B APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. Embo J 1998, 17:215-222
63. Koopman LA, Szuhai K, van Eendenburg JD, Bezrookove V, Kenter GG, Schuuring E, Tanke H and Fleuren GJ Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Res 1999, 59:5615-5624
64. Sastre-Garau X, Favre M, Couturier J and Orth G Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J Gen Virol 2000, 81:1983-1993
65. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS and Smith DI Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 2000, 60:5916-5921
66. Korenberg JR, Chen XN, Sun Z, Shi ZY, Ma S, Vataru E, Yimlamai D, Weissenbach JS, Shizuya H and Simon MI Human genome anatomy: BACs integrating the genetic and cytogenetic maps for bridging genome and biomedicine. Genome Res 1999, 9:994-1001
67. Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ and Reeve AE Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 1992, 3:279-289
68. Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT and Neri A Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. Oncogene 1993, 8:2839-2845
69. ten Hoeve J, Morris C, Poustka A, Groffen J and Heisterkamp N Isolation of NotI sites from chromosome 22q11. Genomics 1993, 18:588-597
70. Morris C, Luppi M, McDonald M, Barozzi P and Torelli G Fine mapping of an apparently targeted latent human herpesvirus type 6 integration site in chromosome band 17p13.3. J Med Virol 1999, 58:69-75
71. Crossen PE, Morrison MJ, Rodley P, Cochrane J and Morris CM Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet 1999, 113:126-133